Loading...
XSHE002626
Market cap1.18bUSD
Jan 14, Last price  
14.17CNY
1D
2.68%
1Q
-1.19%
Jan 2017
2.02%
IPO
97.15%
Name

Xiamen Kingdomway Group Co

Chart & Performance

D1W1MN
XSHE:002626 chart
P/E
31.23
P/S
2.79
EPS
0.45
Div Yield, %
1.84%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
1.55%
Revenues
3.10b
+3.10%
344,631,742367,958,343536,253,185577,944,959675,975,970670,158,447838,250,2861,203,809,1331,662,750,7972,084,623,6552,872,622,7193,191,784,9333,504,406,6413,616,159,4853,009,229,1353,102,580,918
Net income
277m
+7.50%
31,917,34752,464,461141,527,513132,124,839101,690,559102,130,623194,536,175112,572,991299,767,905474,050,601687,251,342450,709,531959,207,761788,857,879257,397,263276,711,481
CFO
665m
-4.40%
86,260,626109,220,122170,548,74774,063,116121,212,869201,956,793161,384,09581,558,085374,051,843487,204,878886,874,815918,380,174967,849,312847,331,118695,121,586664,503,452
Dividend
Jun 06, 20240.2 CNY/sh
Earnings
May 22, 2025

Profile

Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health resources in China and internationally. It offers a series of raw material products, including coenzyme Q10, Vitamin A, Vitamin D3, microalgae DHA, and plant ARA, as well as provides dietary supplements and sports nutrition products. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.
URL
http://www.kingdomway.com/
IPO date
Oct 28, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,102,581
3.10%
3,009,229
-16.78%
Cost of revenue
2,758,578
2,236,924
Unusual Expense (Income)
NOPBT
344,003
772,305
NOPBT Margin
11.09%
25.66%
Operating Taxes
58,416
66,167
Tax Rate
16.98%
8.57%
NOPAT
285,587
706,138
Net income
276,711
7.50%
257,397
-67.37%
Dividends
(159,156)
(365,961)
Dividend yield
1.58%
2.90%
Proceeds from repurchase of equity
(793)
(30,910)
BB yield
0.01%
0.24%
Debt
Debt current
58,046
612,617
Long-term debt
867,654
718,622
Deferred revenue
53,231
55,057
Other long-term liabilities
11,435
1,488
Net debt
(813,596)
(48,945)
Cash flow
Cash from operating activities
664,503
695,122
CAPEX
(251,785)
Cash from investing activities
(452,089)
Cash from financing activities
(186,102)
FCF
591,599
708,447
Balance
Cash
910,554
787,353
Long term investments
828,741
592,832
Excess cash
1,584,166
1,229,724
Stockholders' equity
3,144,927
2,868,238
Invested Capital
3,128,133
3,549,150
ROIC
8.55%
20.24%
ROCE
7.25%
15.64%
EV
Common stock shares outstanding
614,914
609,935
Price
16.33
-21.19%
20.72
-33.87%
Market cap
10,041,552
-20.54%
12,637,848
-33.87%
EV
9,239,179
12,601,300
EBITDA
552,810
979,506
EV/EBITDA
16.71
12.86
Interest
40,285
36,902
Interest/NOPBT
11.71%
4.78%